Innovations in Pharmaceutical Competition

This chapter explores the dynamic landscape of the pharmaceutical industry, focusing on GLP-1 drug targets and the significant investor interest from companies like Structure Therapeutics and Amgen. It also discusses a pivotal partnership between a biotechnology firm and an AI platform, highlighting the potential of generative AI in advancing drug discovery and development.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app